Felbamate Oral Suspension and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Felbamate Oral Suspension and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: felbamate
Brand name: Felbatol
Synonyms: Felbamate
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Felbamate Oral Suspension-Insulin glargine, recombinant Subcutaneous
- Felbamate Oral Suspension-Insulin glulisine
- Felbamate Oral Suspension-Insulin Glulisine (Cartridges and Pens)
- Felbamate Oral Suspension-Insulin Glulisine (Vials)
- Felbamate Oral Suspension-Insulin glulisine Subcutaneous
- Felbamate Oral Suspension-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Felbamate Tablets
- Insulin glargine and lixisenatide Subcutaneous-Felbatol
- Insulin glargine and lixisenatide Subcutaneous-Felbatol (Felbamate Oral Suspension)
- Insulin glargine and lixisenatide Subcutaneous-Felbatol (Felbamate Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Feldene
- Insulin glargine and lixisenatide Subcutaneous-Felimazole